The present invention relates to a compound having a macromolecular carrier having a plurality of terminal groups, wherein the carbonyl group of serine is linked by a peptide bond or an ester bond directly or via a linker to the terminal groups, a carrier for drug delivery composed of the compound, and a medicament for preventing or treating renal diseases, containing the carrier for drug delivery and a drug bonded to the carrier directly or via a linker or encapsulated therein. According to the present invention, a carrier for drug delivery that is selectively accumulated in kidney in vivo can be provided.

The present invention discloses a polycarboxylic acid water-reducing agent with high adaptability to temperature and a preparation method for preparing the same. The polycarboxylic acid water-reducing agent is prepared by introducing an unsaturated macromonomer D with a temperature-sensitive side chain which could be bonded to the backbone of the polycarboxylic acid through free radical polymerization. The polycarboxylic acid water-reducing agent prepared by the invention has an adsorption group density that can be automatically adjusted with the change of ambient temperature, and thereby shows similar dispersing capability and dispersion retention capability at different ambient temperatures, demonstrating high adaptability to different ambient temperatures. It can be used in a larger temperature range with a constant dosage, which is beneficial to further popularization and application of the polycarboxylic acid water-reducing agent in regions of different climates.

A method for treating or preventing saccharide-related diseases or disorders, comprising administering a therapeutically or prophylactically effective amount of a polymer comprising at least one boronic acid group to a subject having or at risk of having a saccharide-related disease or disorder.

A composition in the form of an injectable aqueous solution, for which the pH is comprised from 6.0 to 8.0, includes at least: a) amylin, an amylin receptor agonist or an amylin analogue; b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid being constituted of glutamic or aspartic units and said hydrophobic radicals Hy chosen according to formula X as defined below: c)

##STR00001##

characterized in that the composition does not include basal insulin for which the isoelectric point IP is comprised from 5.8 to 8.5. The composition also includes a prandial insulin.

A method of synthesizing copper oxide nanoparticles includes preparing a liquid extract of Rumex vesicarius, dissolving copper salt in the liquid extract to provide a solution with copper nanoparticles, adding a base to the solution with copper nanoparticles to form a precipitate including copper oxide nanoparticles. Copper oxide nanoparticles prepared according to the method are effective photocatalysts for degrading organic dyes and antibacterial agents and exhibit anticancer activities.

A method of synthesizing copper oxide nanoparticles includes preparing a liquid extract of Rumex vesicarius, dissolving copper salt in the liquid extract to provide a solution with copper nanoparticles, adding a base to the solution with copper nanoparticles to form a precipitate including copper oxide nanoparticles. Copper oxide nanoparticles prepared according to the method are effective photocatalysts for degrading organic dyes and antibacterial agents and exhibit anticancer activities.

Described herein are systems and methods for the degradation of endogenous protein with the help of a nanocarrier, which has the advantage of easy scale-up and feasibility for in vivo application.

Described herein are systems and methods for the degradation of endogenous protein with the help of a nanocarrier, which has the advantage of easy scale-up and feasibility for in vivo application.

Provided is a polymer comprising a structure of Formula 1 or Formula 3 as provided herein, as well as a method of making the same; a composition comprising the polymer and a nucleic acid and/or polypeptide; and a method of delivering a nucleic acid and/or polypeptide to a cell.

Provided is a polymer comprising a structure of Formula 1 or Formula 3 as provided herein, as well as a method of making the same; a composition comprising the polymer and a nucleic acid and/or polypeptide; and a method of delivering a nucleic acid and/or polypeptide to a cell.